Rexahn Pharmaceuticals Presents Additional Data Supporting Supinoxin as Breast …

Rexahn Pharmaceuticals Presents Additional Data Supporting Supinoxin as Breast …

Rexahn Pharmaceuticals (NYSEMKT:RNN) said it presented additional data that support its Supinoxin for the treatment of triple negative breast cancer at the Targeted Anticancer Therapeutics Congress in Washington DC this week. Recent findings show the …

(Visited 2 times, 1 visits today)
12
Like
Save

Comments

Comments are disabled for this post.